Our data indicate that P16 promoter methylation is highly tumour specific, in contrast to some previously published MSP data, whilst CYCA1 promoter methylation has not previously been investigated in an oral cancer series and also appears to be tumour specific. Here, CDKN2A is linked to neoplasm.